0 NASDAQ Companies - July 24, 2019Rhythm Pharmaceuticals Announces Appointment of Stuart Arbuckle to its Board of DirectorsRead More
0 NASDAQ Companies - July 24, 2019Synthorx Initiates Patient Dosing in Australia and Announces Clearance of IND in the U.S. for Lead Immuno-oncology Product Candidate, THOR-707Read More
0 NASDAQ Companies - July 24, 2019Miragen Therapeutics to Report Second Quarter 2019 Financial Results and Host a Conference Call on August 7thRead More
0 NASDAQ Companies - July 24, 2019Luckin Coffee to Announce Second Quarter 2019 Financial Results on August 14, 2019Read More
0 NASDAQ Companies - July 24, 2019Mustang Bio Receives Orphan Drug Designation for MB-102 (CD123 CAR T) for the Treatment of Acute Myeloid LeukemiaRead More
0 NASDAQ Companies - July 24, 2019Ekso Bionics® Expands Its Medical Portfolio with Upper Body Exoskeleton for RehabilitationRead More
0 NASDAQ Companies - July 24, 2019Surgery Partners, Inc. Announces Second Quarter 2019 Earnings Release Date and Conference Call DetailsRead More
0 NASDAQ Companies - July 24, 2019INAP to Release Second Quarter 2019 Financial Results on August 6, 2019Read More
0 NASDAQ Companies - July 24, 2019HTG Molecular Diagnostics to Announce Second Quarter 2019 Financial Results and Host Conference Call on Tuesday, August 6Read More
